15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 3.7% per year over the past 5 years.
Net income has grown slower than revenue (-17.8% vs -3.7% per year).
Operating margin has contracted, at 10.5% in the latest year.
Free cash flow has declined 11.2% per year over the past 5 years.
Financial health
Total debt ($2.1B) exceeds cash ($33M); net debt is $2.1B.
Total debt has grown faster than revenue (7.1% vs -3.7% per year).
Operating income covered interest expense 2.8× in the latest year, down from 7.4× 5 years ago.
Total debt is 5.9× EBITDA.
Shareholder returns
Dividends have been paid for 15 consecutive years, consuming 106.3% of earnings and 56.3% of free cash flow.
The dividend has declined 17.8% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$3.4B
$145M
30.6%
10.5%
-40.6%
5.3%
$274M
$2.1B
$33M
2024
$3.6B
-$35M
23.9%
5.9%
8.9%
-1.2%
$584M
$2.2B
$72M
2023
$3.6B
-$380M
18.5%
-4.9%
142.2%
-11.1%
$438M
$2.6B
$32M
2022
$3.9B
-$438M
22.2%
-11.1%
—
-10.2%
-$243M
$3.0B
$87M
2021
$4.9B
$513M
29.8%
14.7%
50.6%
10.7%
$165M
$2.3B
$244M
2020
$4.1B
$387M
32.6%
14.2%
55.6%
11.5%
$495M
$1.5B
$17M
2019
$3.2B
$461M
32.3%
13.0%
64.1%
15.2%
$184M
$1.6B
$19M
2018
$2.7B
$64M
32.5%
7.5%
18.0%
2.1%
$274M
$2.0B
$34M
2017
$2.6B
$218M
36.8%
16.4%
33.6%
7.9%
$294M
$1.4B
$121M
2016
$2.5B
$315M
35.9%
17.9%
44.1%
11.4%
$186M
$1.2B
$29M
2015
—
$160M
—
—
25.7%
6.3%
$185M
$1.2B
$51M
2014
—
$167M
—
—
30.1%
8.1%
$153M
$784M
$65M
2013
—
$161M
—
—
22.7%
8.3%
$282M
$571M
$130M
2012
—
$107M
—
—
17.7%
5.1%
$84M
$783M
$132M
2011
—
$168M
—
—
30.0%
8.2%
$49M
$795M
$131M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$1.2B
$112M
31.2%
14.5%
-53.8%
3.5%
$321M
$2.1B
$28M
Mar '26
$1.5B
$239M
41.8%
27.5%
-83.3%
7.0%
$201M
$2.3B
$6M
Dec '25
$354M
-$125M
25.0%
-6.2%
25.0%
-4.1%
-$390M
$2.5B
$8M
Sep '25
$387M
—
6.1%
-38.8%
0.0%
0.0%
$131M
$2.1B
$33M
Jun '25
$1.2B
$149M
32.1%
19.1%
-87.2%
4.8%
$438M
$2.2B
$40M
Mar '25
$1.4B
$218M
39.0%
25.2%
-75.0%
6.1%
$180M
$2.5B
$9M
Dec '24
$367M
-$70M
24.1%
-12.5%
14.5%
-2.2%
-$475M
$2.7B
$6M
Sep '24
$415M
—
-7.1%
-52.1%
0.0%
0.0%
$102M
$2.2B
$72M
Jun '24
$1.2B
—
29.5%
16.6%
0.0%
0.0%
$575M
$2.5B
$280M
Mar '24
$1.5B
—
30.4%
17.8%
0.0%
0.0%
$288M
$2.8B
$65M
Dec '23
$410M
—
15.2%
-11.5%
0.0%
0.0%
-$381M
$3.0B
$10M
Sep '23
$375M
—
-15.2%
-111.1%
0.0%
0.0%
$516M
$2.6B
$32M
Jul '23
$1.1B
—
18.4%
6.9%
—
0.0%
$541M
$3.1B
$27M
Apr '23
$1.5B
—
26.9%
13.5%
—
0.0%
-$158M
$3.6B
$25M
Dec '22
$527M
—
18.2%
-7.9%
—
0.0%
-$461M
$3.4B
$26M
Sep '22
$494M
-$220M
-14.3%
-45.4%
—
-5.1%
$536M
$3.0B
$87M
Jul '22
$1.2B
-$444M
19.9%
-47.4%
—
-8.9%
$430M
$3.5B
$28M
Apr '22
$1.7B
$277M
35.1%
23.1%
—
4.5%
-$397M
$3.8B
$17M
Jan '22
$566M
-$50M
21.0%
-6.3%
-6.0%
-1.0%
-$811M
$3.2B
$16M
Sep '21
$738M
-$48M
17.1%
-5.0%
-4.7%
-1.0%
$450M
$2.3B
$244M
Valuation over time
How the market has priced SMG against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 22.8× (Sep '25) to 26.1× (Nov '26).
The price-to-sales ratio has risen from 1.0× (Mar '23) to 1.1× (Nov '26).
The dividend yield has fallen from 4.1% (Mar '23) to 4.1% (Nov '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is SMG growing its revenue and profit?
Over the past 5 years, Scotts Miracle-Gro Co's revenue has declined 3.7% per year, and net income declined 17.8% per year. These are computed facts, not advice.
How much debt does SMG have?
As of FY2025, Scotts Miracle-Gro Co reported $2.1B of total debt against $33M of cash; operating income covered interest expense 2.8×.
What is SMG's profit margin?
In FY2025, gross margin was 30.6%, operating margin 10.5%, and net margin 4.3%.
What is SMG's P/E ratio?
Scotts Miracle-Gro Co's P/E (TTM) is 26.10 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the SMG stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 26.1× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.